| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Structure Therapeutics Inc. | Director | Stock option (right to buy) | 768K | $6.12M | $7.97 | Aug 3, 2023 | Direct |
| Structure Therapeutics Inc. | Director | Stock option (right to buy) | 206K | $1.64M | $7.97 | Aug 3, 2023 | By Trust |
| Ultragenyx Pharmaceutical Inc. | Director | Common Stock | 27K | $1.21M | $45.00 | Jun 18, 2024 | Direct |
| Nuvation Bio Inc. | Director | Class A Common Stock | 660K | $1.08M | $1.64 | May 24, 2024 | Direct |
| Structure Therapeutics Inc. | Director | Share Option (right to buy) | 37.5K | Jun 25, 2024 | Direct | ||
| PROTHENA CORP PUBLIC LTD CO | Director | Stock Option (Right to Buy) | 15K | May 15, 2024 | Direct | ||
| Ultragenyx Pharmaceutical Inc. | Director | Stock Option (Right to Buy) | 9.9K | Jun 18, 2024 | Direct | ||
| Nuvation Bio Inc. | Director | Stock Option (Right to Buy) | 0 | May 24, 2024 | Direct | ||
| Seagen Inc. | Director | Common Stock | 0 | $229.00 | Dec 14, 2023 | by Trust | |
| Seagen Inc. | Director | Common Stock | 0 | $229.00 | Dec 14, 2023 | Direct | |
| Seagen Inc. | Director | Restricted Stock Units | 0 | $229.00 | Dec 14, 2023 | Direct | |
| Seagen Inc. | Director | Non-Qualified Stock Option (right to buy) | 0 | Aug 28, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| GPCR | Structure Therapeutics Inc. | Jun 25, 2024 | 1 | $0 | 4 | Jun 27, 2024 | Director |
| RARE | Ultragenyx Pharmaceutical Inc. | Jun 18, 2024 | 2 | $0 | 4 | Jun 20, 2024 | Director |
| NUVB | Nuvation Bio Inc. | May 24, 2024 | 4 | $1.11M | 4 | May 29, 2024 | Director |
| PRTA | PROTHENA CORP PUBLIC LTD CO | May 15, 2024 | 1 | $0 | 4 | May 17, 2024 | Director |
| PRTA | PROTHENA CORP PUBLIC LTD CO | Feb 21, 2024 | 1 | $0 | 4 | Feb 23, 2024 | Director |
| PRTA | PROTHENA CORP PUBLIC LTD CO | Feb 21, 2024 | 0 | $0 | 3 | Feb 23, 2024 | Director |
| SGEN | Seagen Inc. | Dec 14, 2023 | 3 | -$3.54M | 4 | Dec 15, 2023 | Director |
| SGEN | Seagen Inc. | Aug 28, 2023 | 5 | -$784K | 4 | Aug 29, 2023 | Director |
| GPCR | Structure Therapeutics Inc. | Aug 3, 2023 | 3 | $0 | 4 | Aug 4, 2023 | Director |
| RARE | Ultragenyx Pharmaceutical Inc. | Jun 7, 2023 | 2 | $0 | 4 | Jun 9, 2023 | Director |
| SGEN | Seagen Inc. | May 31, 2023 | 1 | $0 | 4 | Jun 2, 2023 | Director |
| NUVB | Nuvation Bio Inc. | May 15, 2023 | 1 | $0 | 4 | May 17, 2023 | Director |
| SGEN | Seagen Inc. | May 15, 2023 | 3 | -$120K | 4 | May 16, 2023 | Director |
| SGEN | Seagen Inc. | May 1, 2023 | 19 | -$3.82M | 4 | May 3, 2023 | Director |
| SGEN | Seagen Inc. | Apr 3, 2023 | 0 | $0 | 4/A | Apr 12, 2023 | Director |
| SGEN | Seagen Inc. | Mar 15, 2023 | 5 | -$642K | 4 | Mar 17, 2023 | Director |
| SGEN | Seagen Inc. | Mar 13, 2023 | 23 | -$4.88M | 4 | Mar 16, 2023 | Director |
| GPCR | Structure Therapeutics Inc. | Feb 7, 2023 | 2 | $0 | 4 | Feb 9, 2023 | Director |
| GPCR | Structure Therapeutics Inc. | Feb 2, 2023 | 0 | $0 | 3 | Feb 2, 2023 | Director |
| RARE | Ultragenyx Pharmaceutical Inc. | Jun 24, 2022 | 2 | $0 | 4 | Jun 28, 2022 | Director |
| NUVB | Nuvation Bio Inc. | May 16, 2022 | 1 | $0 | 4/A | Jun 28, 2022 | Director |
| SGEN | Seagen Inc. | May 13, 2022 | 2 | $0 | 4 | May 17, 2022 | Director |
| SGEN | Seagen Inc. | Dec 31, 2021 | 2 | $0 | 5 | Feb 11, 2022 | Director |
| NUVB | Nuvation Bio Inc. | Oct 29, 2021 | 1 | $0 | 4 | Nov 2, 2021 | Director |
| RARE | Ultragenyx Pharmaceutical Inc. | Jun 24, 2021 | 2 | $0 | 4 | Jun 28, 2021 | Director |
| SGEN | Seagen Inc. | May 14, 2021 | 2 | $0 | 4 | May 18, 2021 | Director |